DRUGGING THE UNDRUGGABLE®
for the next generation of therapies
How we are expanding druggable space
PhoreMost is applying its proprietary SITESEEKER® technology to drive the discovery of tomorrow’s medicines
We are advancing a pipeline of novel targets in oncology and Targeted Protein Degradation (TPD)
View our pipeline and learn more about SITESEEKER®We collaborate with a wide range of industry partners to develop ground-breaking medicines against challenging diseases
Find out more about partnering with us
